Two Healthcare Blue-Chip Stocks Offer Opportunities as Dividends Shine Bright for Pfizer and Bristol-Myers Squibb Life Science
Biotech Double Winners Outperform the Market, With Fundamental Tailwinds Poised to Sustain Momentum Life Science
Eli Lilly Stock Hits Record High as Analysts Bullish on Weight-Loss Drug Market Prospects Life Science
The Shadow of a Tech Stock Pullback Looms, Jefferies Screens Top Ten Low-Momentum High-Quality Stocks as a Defensive Guide Life Science, Technology
The $10 Billion Acquisition Is Set, as Vertex Pharmaceuticals Bets on a New Blue Ocean in Rare Endocrine Diseases Life Science
TransMedics Is Betting on Kidney Transplants and European Expansion Despite a 40% Stock Drop in Six Months, Yet Long-Term Prospects Remain Strong Life Science
Significant Improvement in AI Investment Returns Enhances Earnings Prospects, Bullish Logic for Blue-Chip UnitedHealth Is Reshaping Life Science
Pharmaceutical Giant AbbVie Makes a Major Bet on a New Immunotherapy, and Its Dividend Growth Record Attracts Income-Focused Investors Life Science
Small-Cap U.S. Stocks Trounce S&P 500 in First Half; Seven Top Small-Cap ETFs to Watch Financial Service, Life Science, Technology
Anthropic Launches Claude Science to Enter Life Sciences, AI Drug Discovery Stocks Tumble in Response Life Science
